This important meeting, held at the John McIntyre Centre in Edinburgh on 7/8 October 2019, was brought to you by the UK Regenerative Medicine Platform (UKRMP) and the British Pharmacological Society.
Stem cell-derived therapies are complex and diverse, so it is critical that we understand the challenges faced in getting clinical trials for these therapies approved.
Across two days, we discussed how some therapies have made progress towards clinical trials, particularly in relation to assessing safety. We also looked at areas where new technologies can fill vital gaps, such as in combination therapies with smart materials.
The meeting was attended pharmacologists, working in toxicology, clinicians, academics and industry. Regulators, including MHRA and FDA, also joined our panel discussions.
Delegates were able to hear from leaders in the field including Pete Coffey, Agnete Kirkeby, Martin Pera, Kevin Eggan and our key note speaker, Jane Lebkowski.